DG013A
DG013A is a zinc-dependent M1-aminopeptidase inhibitor that exhibits inhibitory activity against ERAP1 (IC50 = 33 nM) and ERAP2 (IC50 = 11 nM). DG013A enhances SRHFLAFSFR epitope presentation, rescues GSW11 peptide neoantigen presentation, reduces SIINFEKL presentation, modulates the immunopeptidome, decreases HLA-B27 free heavy chain expression, and reduces IL-17A secretion. DG013A exhibits antiproliferative activity. DG013A can be used for research on autoimmune diseases and melanoma.
For research use only. We do not sell to patients.
- CAS No.: 2007955-07-7
- Formula: C27H37N4O4P
- Molecular Weight:512.58
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[2]|
IL-17A |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HeLa | ED50 |
350 nM
|
Inhibition of ERAP1-dependent antigen presentation of the SIINFEKL epitope on the cell surface of HeLa cells stably expressing H-2 Kb infected with recombinant vaccinia virus, measured by flow cytometry after 18-22 hrs.
Inhibition of ERAP1-dependent antigen presentation of the SIINFEKL epitope on the cell surface of HeLa cells stably expressing H-2 Kb infected with recombinant vaccinia virus, measured by flow cytometry after 18-22 hrs.
|
31222486 |
In Vitro
DG013A is a moderate inhibitor of ERAP1 and ERAP2, but acts as a highly potent inhibitor of the off-target M1-aminopeptidase APN (IC50 = 0.0037 μM)[1].
DG013A exhibits negligible passive permeability in Caco-2 cells, which is inconsistent with its use as a convertible intracellular chemical probe[1].
DG013A is a potent nanomolar ERAP1 inhibitor (IC50 = 33 nM) and ERAP2 inhibitor (IC50 = 11 nM), and it also inhibits IRAP and APN, with its binding to ERAP2 involving coordination of its phosphonic acid group with the active-site zinc ion[2].
DG013A is a potent inhibitor of recombinant ERAP1 with an IC50 of 43.5 nM[3].
DG013A shows weak antiproliferative activity in HCT116 cells, possibly due to off-target effects[1].
DG013A (0-30 μM; 48 h) shows no toxicity toward A375 malignant melanoma cells at concentrations up to 30 μM for 48 h[3].
DG013A modulates antigen presentation and the immunopeptidome in HeLa-B27, CT26, and melanoma cells[2].
DG013A (1 μM; 6 days) does not significantly alter cell surface MHC-I levels in A375 malignant melanoma cells within 6 days[3].
DG013A (18-22 h) inhibits ERAP1-dependent SIINFEKL epitope antigen presentation in H-2 Kb-expressing HeLa cells with an apparent ED50 of 350 nM[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A375 human malignant melanoma cells
-
Concentration:0-30 μM
-
Incubation Time:48 h
-
Result:Did not appear to be toxic to A375 cells up to a concentration of 30 μM.
Chemical Information
-
CAS No. 2007955-07-7
-
Molecular Weight 512.58
-
Formula C27H37N4O4P
-
SMILES
O=P([C@@H](N)CCC1=CC=CC=C1)(O)C[C@@H](CC(C)C)C(N[C@H](C(N)=O)CC2=CNC3=CC=CC=C23)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Serum-Free B27/Neurobasal Neuronal Maintenance Culture
Serum-free B27/Neurobasal culture is a defined neuronal maintenance method designed to support dissociated primary neurons while limiting serum-driven glial expansion; the readout is sustained neuronal survival, neurite extension, neuronal marker expression, synapse formation, and, when measured, electrophysiological or calcium activity. B27/Neurobasal was optimized in embryonic rat hippocampal neurons, where B27 supported >60% survival after 4 days above 160 plated cells/mm2 and Neurobasal reduced glial growth to <0. 5% by immunocytochemistry; later studies extended the approach to cortex, striatum, substantia nigra, septum, cerebellum, and dentate gyrus neurons.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)